Suppr超能文献

术前分级量表预测恶性原发性骨脊柱肿瘤切除术患者的生存情况。

Preoperative grading scale to predict survival in patients undergoing resection of malignant primary osseous spinal neoplasms.

机构信息

Department of Neurological Surgery, Vanderbilt University Medical Center, 4340 The Village at Vanderbilt, Nashville, TN 37232-8618, USA.

出版信息

Spine J. 2011 Mar;11(3):190-6. doi: 10.1016/j.spinee.2011.01.013. Epub 2011 Feb 2.

Abstract

BACKGROUND CONTEXT

Large population-based studies of malignant primary osseous spinal neoplasms are lacking and are necessary to have sufficient statistical power to determine if various patient-related factors are in fact significant indicators of prognosis.

PURPOSE

Using a 30-year US national cancer registry (Surveillance, Epidemiology, and End Results [SEER]), we introduce a preoperative grading scale that is associated with survival in patients undergoing surgical resection for malignant primary osseous spinal neoplasms.

STUDY DESIGN

Large-scale retrospective study.

PATIENT SAMPLE

SEER registry.

OUTCOME MEASURE

Survival.

METHODS

The SEER registry (1973-2003) was queried to identify adult patients undergoing surgical resection of histologically confirmed primary spinal chordoma, chondrosarcoma, or osteosarcoma via International Classification of Disease for Oncology, Third Edition coding. Variables independently associated with survival were determined via Cox proportional hazards regression analysis for all tumor types. A grading scale comprising these independent survival predictors was then developed and applied to each histology-specific tumor cohort.

RESULTS

Three hundred forty-two patients who underwent surgical resection of a malignant primary osseous spinal neoplasm (114 chordoma, 156 chondrosarcoma, and 72 osteosarcoma) were identified. Overall median survival after surgical resection was histology specific (osteosarcoma: 22 months; chordoma: 100 months; and chondrosarcoma: 160 months). Increasing age (years) and increasing tumor invasion (confined to periosteum; invasion through periosteum into adjacent tissues; and distal site metastasis) were the only variables independently associated with decreased survival (p<.05) for all tumor types. For spinal chordoma, sacrum/pelvic location (p<.05) and earlier year of surgery (p<.005) were also independently associated with decreased survival. Using variables of patient age, extent of local tumor invasion, and metastasis status in a five-point grading scale, increasing score (1-5) closely correlated (p<.001) with decreased survival for chordoma, chondrosarcoma, and osteosarcoma.

CONCLUSIONS

In our analysis of a US population-based cancer registry (SEER), a grading scale consisting of age, metastasis status, and extent of local tumor invasion was associated with overall survival after surgical resection of chordoma, chondrosarcoma, and osteosarcoma of the spine. Although this analysis could not take into account specific chemotherapy regimens and variations in surgical technique, this grading scale may offer valuable prognostic data based on variables available to the surgeon and patient before surgery and may help guide level of aggressiveness in subsequent treatment strategies.

摘要

背景

缺乏对恶性原发性骨脊柱肿瘤的大规模基于人群的研究,为了有足够的统计能力来确定各种与患者相关的因素是否实际上是预后的重要指标,这些研究是必要的。

目的

我们使用美国国家癌症登记处(监测、流行病学和最终结果[SEER])30 年的数据,引入了一种术前分级量表,该量表与接受手术切除的恶性原发性骨脊柱肿瘤患者的生存相关。

研究设计

大规模回顾性研究。

患者样本

SEER 登记处。

预后指标

生存。

方法

通过国际肿瘤疾病分类第三版(ICD-O-3)编码,查询 SEER 登记处(1973-2003 年),以确定接受手术切除组织学证实的原发性脊髓脊索瘤、软骨肉瘤或骨肉瘤的成年患者。通过 Cox 比例风险回归分析确定所有肿瘤类型中与生存相关的独立变量。然后,开发了一个包含这些独立生存预测因素的分级量表,并将其应用于每个组织学特异性肿瘤队列。

结果

确定了 342 名接受恶性原发性骨脊柱肿瘤手术切除的患者(114 例脊索瘤、156 例软骨肉瘤和 72 例骨肉瘤)。手术切除后的总体中位生存时间因组织学而异(骨肉瘤:22 个月;脊索瘤:100 个月;软骨肉瘤:160 个月)。对于所有肿瘤类型,年龄增加(岁)和肿瘤侵袭范围增加(局限于骨膜;穿透骨膜进入相邻组织;远处转移)是唯一与生存时间缩短相关的变量(p<.05)。对于脊柱脊索瘤,骶骨/骨盆位置(p<.05)和手术年份较早(p<.005)也是与生存时间缩短相关的独立因素。在一个五级评分量表中使用患者年龄、局部肿瘤侵袭程度和转移状态等变量,评分增加(1-5)与脊索瘤、软骨肉瘤和骨肉瘤的生存时间缩短密切相关(p<.001)。

结论

在我们对美国基于人群的癌症登记处(SEER)的分析中,一个由年龄、转移状态和局部肿瘤侵袭范围组成的分级量表与脊柱脊索瘤、软骨肉瘤和骨肉瘤手术切除后的总体生存率相关。尽管该分析无法考虑特定的化疗方案和手术技术的差异,但该分级量表可以根据手术前外科医生和患者可获得的变量提供有价值的预后数据,并可能有助于指导后续治疗策略的侵袭性水平。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验